Overview
NMPA manages device registration clinical evaluation and market surveillance for imaging modalities in China.
Modality Specifics
Local testing and technical standards may apply for CT MRI ultrasound and nuclear medicine devices.
Market Impact
NMPA pathways and local requirements influence global manufacturers seeking access to the Chinese imaging market.
Regulatory Trends
NMPA participates in international harmonization efforts while maintaining national technical guidance.